Bottom line
How much do XLV and GGHCX overlap?
55% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 58.4% of XLV's assets and 44.0% of GGHCX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings XLV and GGHCX have in common
| Holding | % of XLV | % of GGHCX | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 16.51% | 10.59% | 10.59% |
| Johnson & Johnson | 10.64% | 6.76% | 6.76% |
| AbbVie Inc | 7.74% | 4.03% | 4.03% |
| UnitedHealth Group Inc | 6.57% | 6.17% | 6.17% |
| Merck & Co Inc | 5.52% | 4.59% | 4.59% |
| Thermo Fisher Scientific Inc | 3.24% | 1.55% | 1.55% |
| Gilead Sciences Inc | 2.73% | 3.63% | 2.73% |
| CVS Health Corp | 2.30% | 2.52% | 2.30% |
| Vertex Pharmaceuticals Inc | 2.19% | 2.01% | 2.01% |
| Cardinal Health Inc | 0.97% | 2.10% | 0.97% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in XLV
- Amgen Inc — 3.40%
- Abbott Laboratories — 2.75%
- Intuitive Surgical Inc — 2.45%
- Pfizer Inc — 2.39%
- Danaher Corp — 2.09%
- Bristol-Myers Squibb Co — 2.05%
- Stryker Corp — 1.89%
- Medtronic PLC — 1.75%
- McKesson Corp — 1.58%
- Elevance Health Inc — 1.46%
- Cigna Group/The — 1.27%
- Boston Scientific Corp — 1.10%
- Regeneron Pharmaceuticals Inc — 1.08%
- HCA Healthcare Inc — 1.05%
- Cencora Inc — 0.96%
Only in GGHCX
- Invesco Private Prime Fund — 4.67%
- argenx SE — 3.24%
- Welltower Inc. — 2.34%
- BrightSpring Health Services, Inc. — 2.20%
- Royalty Pharma PLC — 2.13%
- Guardant Health, Inc. — 2.04%
- Invesco Private Government Fund — 1.80%
- Axsome Therapeutics, Inc. — 1.58%
- Edwards Lifesciences Corp. — 1.56%
- Invesco Treasury Portfolio — 1.56%
- BridgeBio Pharma, Inc. — 1.43%
- Waters Corp. — 1.41%
- IQVIA Holdings Inc. — 1.32%
- U C B S.a. — 1.24%
- Ligand Pharmaceuticals Inc. — 1.18%
Asset mix
| Asset type | XLV | GGHCX |
|---|---|---|
| Stocks | 99.7% | 97.5% |
| Cash & short-term funds | 0.3% | 8.8% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Country mix
| Country | XLV | GGHCX |
|---|---|---|
| US | 97.9% | 93.5% |
| NL | — | 3.4% |
| GB | — | 3.1% |
| CH | — | 2.7% |
| IE | 2.1% | 0.6% |
| BE | — | 1.2% |
| DK | — | 1.1% |
| IL | — | 0.4% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do XLV and GGHCX overlap?
What stocks do XLV and GGHCX have in common?
Should I own both XLV and GGHCX?
Which holds more stocks, XLV or GGHCX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.